Skip to content

Doximity DOCS EPS (Diluted)

EPS (Diluted) at other companies

Microsoft logo
MicrosoftMSFT
$4.27+23.4%
Veeva Systems logo
Veeva SystemsVEEV
$1.57+14.6%
Solventum logo
SolventumSOLV
$0.07-91.0%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$0.67+379%
Cencora logo
CencoraCOR
$8.40+128%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$0.19+375%

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.74B-60.5%
Enterprise value$3.53B-61.7%
P/E19.1×-23.3×
P/S5.8×-10.8×

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's EPS (diluted)?
Doximity (DOCS) reported EPS (diluted) of $0.10 in Q1 2026.
How has Doximity's EPS (diluted) changed year-over-year?
Doximity's EPS (diluted) decreased by 67.7% year-over-year, from $0.31 to $0.10.
What is the long-term trend for Doximity's EPS (diluted)?
Over 4 years (2022 to 2026), Doximity's EPS (diluted) has grown at a 9.4% compound annual growth rate (CAGR), from $0.69 to $0.99.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.